A pharmaceutical reinsurance mechanism could help fund high-cost research and minimize the market uncertainty that often impairs drug development efforts, thereby stimulating innovation. How would such a mechanism work? Bruce Pyenson explains the concept.
Read or print the article
About the Author(s)
Adapting reinsurance to relieve biotech bottleneck
A pharmaceutical reinsurance mechanism could help fund high cost research and minimize the market uncertainty that often impairs drug development efforts, thereby stimulating innovation. How would such a mechanism work? Bruce Pyenson explains the concept. Read or print the article
Bruce Pyenson